ArrowArtboardCreated with Sketch.Title ChevronTitle ChevronIcon FacebookIcon LinkedinIcon Mail ContactPath LayerIcon MailPositive ArrowIcon Print

Chinese medical technology startup SiBionics raises nearly $72m

Company will use funds to expand at home and overseas

Founded in 2015, SiBionics is developing a pipeline of products focused on a range of diseases. (Source image from SiBionics website)

HONG KONG -- Chinese medical technology startup SiBionics has raised nearly 500 million yuan ($72 million) in a Series D round of financing to expand its development of artificial intelligence-based devices for chronic disease management.

Shenzhen-based SiBionics this week announced it had secured the new financing from lead investors Shanghai Biomedical Industrial Equity Investment Fund and Guangdong Chinese Medicine and Mass Health Fund.

Sponsored Content

About Sponsored Content This content was commissioned by Nikkei's Global Business Bureau.

Nikkei Asian Review, now known as Nikkei Asia, will be the voice of the Asian Century.

Celebrate our next chapter
Free access for everyone - Sep. 30

Find out more